BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8279612)

  • 41. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis.
    Forouzanfar MH; Foreman KJ; Delossantos AM; Lozano R; Lopez AD; Murray CJ; Naghavi M
    Lancet; 2011 Oct; 378(9801):1461-84. PubMed ID: 21924486
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening?
    Carlos RC; Fendrick AM; Ellis J; Bernstein SJ
    J Am Coll Radiol; 2004 Oct; 1(10):769-76. PubMed ID: 17411698
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Is the benefit of organized mass screening for cervix cancer and breast cancer in Norway scientifically justified?].
    Zahl PH
    Tidsskr Nor Laegeforen; 2000 Jun; 120(17):2002-5. PubMed ID: 11008534
    [TBL] [Abstract][Full Text] [Related]  

  • 44. History, development and future of cancer screening in Australia.
    Olver IN; Roder D
    Public Health Res Pract; 2017 Jul; 27(3):. PubMed ID: 28765858
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Five common cancers in Iran.
    Kolahdoozan S; Sadjadi A; Radmard AR; Khademi H
    Arch Iran Med; 2010 Mar; 13(2):143-6. PubMed ID: 20187669
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Some interpretation of regional estimates of the incidence of cancer in France over the period 1980--2005].
    Colonna M; Bossard N; Mitton N; Remontet L; Belot A; Delafosse P; Grosclaude P;
    Rev Epidemiol Sante Publique; 2008 Dec; 56(6):434-40. PubMed ID: 19010627
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium.
    Tosteson AN; Beaber EF; Tiro J; Kim J; McCarthy AM; Quinn VP; Doria-Rose VP; Wheeler CM; Barlow WE; Bronson M; Garcia M; Corley DA; Haas JS; Halm EA; Kamineni A; Rutter CM; Tosteson TD; Trentham-Dietz A; Weaver DL;
    J Gen Intern Med; 2016 Apr; 31(4):372-9. PubMed ID: 26658934
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recommendation for and receipt of cancer screenings among medicaid recipients 50 years and older.
    DuBard CA; Schmid D; Yow A; Rogers AB; Lawrence WW
    Arch Intern Med; 2008 Oct; 168(18):2014-21. PubMed ID: 18852404
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expected years of life lost for six potentially preventable cancers in the United States.
    Liu PH; Wang JD; Keating NL
    Prev Med; 2013 May; 56(5):309-13. PubMed ID: 23428566
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spatial analysis of breast and cervical cancer incidence in small geographical areas in Cuba, 1999-2003.
    Lorenzo-Luaces Alvarez P; Guerra-Yi ME; Faes C; Galán Alvarez Y; Molenberghs G
    Eur J Cancer Prev; 2009 Sep; 18(5):395-403. PubMed ID: 19609213
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surveillance for certain health behaviors among selected local areas--United States, Behavioral Risk Factor Surveillance System, 2002.
    Balluz L; Ahluwalia IB; Murphy W; Mokdad A; Giles W; Harris VB
    MMWR Surveill Summ; 2004 Jul; 53(5):1-100. PubMed ID: 15269697
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cancer: incidence and deaths in Canada, 1990.
    Gaudette L; Lee J; Silberberger C
    Health Rep; 1993; 5(4):348-54. PubMed ID: 8011953
    [No Abstract]   [Full Text] [Related]  

  • 53. Neighborhood composition and incidence of cancer among Hispanics in the United States.
    Eschbach K; Mahnken JD; Goodwin JS
    Cancer; 2005 Mar; 103(5):1036-44. PubMed ID: 15672387
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Awareness and uptake of colorectal, breast, cervical and prostate cancer screening tests in Spain.
    Carrasco-Garrido P; Hernandez-Barrera V; Lopez de Andres A; Jimenez-Trujillo I; Gallardo Pino C; Jimenez-Garcıa R
    Eur J Public Health; 2014 Apr; 24(2):264-70. PubMed ID: 23813710
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of early diagnosis and screening; biomarkers.
    Miller AB
    Cancer Detect Prev; 1991; 15(1):21-6. PubMed ID: 2044070
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Trends and social indicators of both mortality breast cancer and cervical cancer in Antioquia, Colombia, 2000-2007].
    Baena A; Almonte M; Valencia ML; Martínez S; Quintero K; Sánchez GI
    Salud Publica Mex; 2011; 53(6):486-92. PubMed ID: 22282141
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Breast and cervical cancer screening programme implementation in 16 countries.
    Dowling EC; Klabunde C; Patnick J; Ballard-Barbash R;
    J Med Screen; 2010; 17(3):139-46. PubMed ID: 20956724
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analyzing geographic patterns of disease incidence: rates of late-stage colorectal cancer in Iowa.
    Rushton G; Peleg I; Banerjee A; Smith G; West M
    J Med Syst; 2004 Jun; 28(3):223-36. PubMed ID: 15446614
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Constructing regions for small area analysis: material deprivation and colorectal cancer.
    Haining R; Wise S; Blake M
    J Public Health Med; 1994 Dec; 16(4):429-38. PubMed ID: 7880574
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stage-shift cancer screening model.
    Connor RJ; Chu KC; Smart CR
    J Clin Epidemiol; 1989; 42(11):1083-95. PubMed ID: 2681551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.